GOLDMAN SACHS GROUP INC Aardvark Therapeutics, Inc. Common Stock (AARD) 13F holding

GOLDMAN SACHS GROUP INC reported 19,404 AARD shares valued at $73.2M as of 2026-03-31 (CMN). Cached 13F row, not a live tape.

Not investment advice. Cached 13F row, not EDGAR XML.